{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2006-N-0515\" and posted_year = 2014 sorted by posted_date descending", "rows": [["FDA-2006-N-0515-0091", "FDA", "FDA-2006-N-0515", "Reference 4 Evaluation of How Best to Communicate with Healthcare Providers about the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women A Mental Models Research Report Final Report re Ref2 Final Regulatory Impact Analysis for Docket No. FDA-2006-N-0515 (formerly Docket No. 2006N-0467)", "Supporting & Related Material", "Background Material", "2014-12-30T05:00:00Z", 2014, 12, null, null, "2014-12-30T18:22:18Z", null, 0, 0, "090000648199a463"], ["FDA-2006-N-0515-0074", "FDA", "FDA-2006-N-0515", "Reference 5 - Adam, M. P., J. E. Polifka, and J. M. Friedman, \"Evolving Knowledge of the Teratogenicity of Medications in Human Pregnancy.\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:48:28Z", null, 0, 0, "090000648195b8ba"], ["FDA-2006-N-0515-0080", "FDA", "FDA-2006-N-0515", "Reference 11 - U.S. Food and Drug Administration, \"Reviewer Guidance, Evaluating the Risks of Drug Exposure in Human Pregnancies,\" 2005. re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:49:09Z", null, 0, 0, "090000648195b8e1"], ["FDA-2006-N-0515-0083", "FDA", "FDA-2006-N-0515", "Reference 14 - Tracy, T. S., et al. \"Temporal Changes in Drug Metabolism (CYP1A2, CYP2D6 and CYP3A Activity) During Pregnancy.\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:49:29Z", null, 0, 0, "090000648195b8e5"], ["FDA-2006-N-0515-0075", "FDA", "FDA-2006-N-0515", "Reference 6 - Law, R., P. Bozzo, G. Koren, et al. \"FDA Pregnancy Risk Categories and the CPS. Do They Help or Are They a Hindrance?\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:48:36Z", null, 0, 0, "090000648195b8dc"], ["FDA-2006-N-0515-0071", "FDA", "FDA-2006-N-0515", "Reference 2 - Final Regulatory Impact Analysis for Docket No. FDA-2006-N-0515 (formerly Docket No. 2006N-0467) re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:48:10Z", null, 0, 0, "090000648195b8b7"], ["FDA-2006-N-0515-0072", "FDA", "FDA-2006-N-0515", "Reference 3 - U.S. Food and Drug Administration, \"Guidance for Industry, Warnings and Precautions, Contraindications, and Boxed Warning Sections of Labeling for Human Prescription Drug and Biological Products--Content and Format,\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:48:15Z", null, 0, 0, "090000648195b8b8"], ["FDA-2006-N-0515-0078", "FDA", "FDA-2006-N-0515", "Reference 9 - Rynn, L., J. Cragan, and A. Correa, \"Update on Overall Prevalence of Major Birth Defects--Atlanta, Georgia, 1978-2005.\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:48:56Z", null, 0, 0, "090000648195b8df"], ["FDA-2006-N-0515-0084", "FDA", "FDA-2006-N-0515", "Reference 15 - Anderson, G. D., \"Pregnancy-Induced Changes in Pharmacokinetics.\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:49:36Z", null, 0, 0, "090000648195b8e6"], ["FDA-2006-N-0515-0082", "FDA", "FDA-2006-N-0515", "Reference 13 - FDA, \"Guidance for industry, M3 (R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing\nAuthorization for Pharmaceuticals and the International Conference on Harmonisation S5 (R2) Guideline: Detection of Toxicity to Reproduction for Medicinal Products and Toxicity to Male Fertility,\". re Content and Format of Labeling for Human Prescription Drug", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:49:22Z", null, 0, 0, "090000648195b8e3"], ["FDA-2006-N-0515-0087", "FDA", "FDA-2006-N-0515", "Reference 18 U.S. Food and Drug Administration, \"Draft Guidance for industry Clinical Lactation Studies--Study Design, Data Analysis, and Recommendations for Labeling,\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:49:53Z", null, 0, 0, "090000648195b8e9"], ["FDA-2006-N-0515-0086", "FDA", "FDA-2006-N-0515", "Reference 17 - Sachs, H. C. and Committee on Drugs. \"The Transfer of Drugs and Therapeutics Into Human Breast Milk: An Update on Selected Topics.\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:49:47Z", null, 0, 0, "090000648195b8e8"], ["FDA-2006-N-0515-0076", "FDA", "FDA-2006-N-0515", "Reference 7 - U.S. Food and Drug Administration \"Guidance for industry, Establishing Pregnancy Exposure Registries,\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:48:42Z", null, 0, 0, "090000648195b8dd"], ["FDA-2006-N-0515-0070", "FDA", "FDA-2006-N-0515", "Reference 1 - Decision Partners, LLC, \"Evaluation of How Best to Communicate to Healthcare Providers about the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women: A Mental Models Research Report,\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:48:03Z", null, 0, 0, "090000648195b8b5"], ["FDA-2006-N-0515-0069", "FDA", "FDA-2006-N-0515", "References List  re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:43:25Z", null, 0, 0, "090000648195b8b4"], ["FDA-2006-N-0515-0079", "FDA", "FDA-2006-N-0515", "Reference 10 - American College of Obstetricians and Gynecologists Frequently Asked Questions: Miscarriage and Molar Pregnancy, 2011 re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:49:02Z", null, 0, 0, "090000648195b8e0"], ["FDA-2006-N-0515-0073", "FDA", "FDA-2006-N-0515", "Reference 4 - Kweder, S. L., \"Drugs and Biologics in Pregnancy and Breastfeeding: FDA in the 21st Century.\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:48:22Z", null, 0, 0, "090000648195b8b9"], ["FDA-2006-N-0515-0077", "FDA", "FDA-2006-N-0515", "Reference 8 - U.S. Food and Drug Administration \"Guidance for Industry, Reproductive and Developmental Toxicities--Integrating Study Results to Assess Concerns,\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:48:49Z", null, 0, 0, "090000648195b8de"], ["FDA-2006-N-0515-0081", "FDA", "FDA-2006-N-0515", "Reference 12 - U.S. Food and Drug Administration, \"Guidance for industry, Considerations for Developmental Toxicity Studies for Preventive and Therapeutic Vaccines for Infectious Disease Indications,\" 2006. re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:49:15Z", null, 0, 0, "090000648195b8e2"], ["FDA-2006-N-0515-0085", "FDA", "FDA-2006-N-0515", "Reference 16 - American Academy of Pediatrics Policy Statement. \"Breastfeeding and the Use of Human Milk.\" re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling", "Supporting & Related Material", "Background Material", "2014-12-05T05:00:00Z", 2014, 12, null, null, "2014-12-05T14:49:41Z", null, 0, 0, "090000648195b8e7"], ["FDA-2006-N-0515-0090", "FDA", "FDA-2006-N-0515", "Reference 3 Final Report Evaluation of How Best to Communicate to Healthcare Providers about the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women re Ref2 Final Regulatory Impact Analysis for Docket No. FDA-2006-N-0515 (formerly Docket No. 2006N-0467)", "Supporting & Related Material", "Background Material", "2014-12-04T05:00:00Z", 2014, 12, null, null, "2014-12-30T18:20:07Z", null, 0, 0, "090000648199a462"], ["FDA-2006-N-0515-0068", "FDA", "FDA-2006-N-0515", "Content and Format of Labeling for Human Prescription Drug and\nBiological Products; Requirements for Pregnancy and Lactation Labeling", "Rule", "Final Rule", "2014-12-04T05:00:00Z", 2014, 12, "2014-12-04T05:00:00Z", null, "2014-12-04T15:08:11Z", "2014-28241", 0, 0, "090000648195a53f"], ["FDA-2006-N-0515-0088", "FDA", "FDA-2006-N-0515", "Reference 1 U.S. Bureau of Labor Statistics Occupational Employment Statistics May 2011 National Industry-Specific Occupational Employment and Wage Estimates NAICS 325400 - Pharmaceutical and Medicine Manufacturingre Ref2 Final Regulatory Impact Analysis for Docket No. FDA-2006-N-0515 (formerly Docket No. 2006N-0467)", "Supporting & Related Material", "Background Material", "2014-12-04T05:00:00Z", 2014, 12, null, null, "2014-12-30T18:19:43Z", null, 0, 0, "090000648199a460"], ["FDA-2006-N-0515-0089", "FDA", "FDA-2006-N-0515", "Reference 2 O'Reilly, Pharma scales back drug samples to physician offices re Ref2 Final Regulatory Impact Analysis for Docket No. FDA-2006-N-0515 (formerly Docket No. 2006N-0467)", "Supporting & Related Material", "Background Material", "2014-12-04T05:00:00Z", 2014, 12, null, null, "2014-12-30T18:19:54Z", null, 0, 0, "090000648199a461"]], "truncated": false, "filtered_table_rows_count": 24, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2006-N-0515", "p1": "2014"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2006-N-0515&posted_year=2014", "results": [{"value": "FDA", "label": "FDA", "count": 24, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-N-0515&posted_year=2014&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2006-N-0515&posted_year=2014", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 23, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-N-0515&posted_year=2014&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-N-0515&posted_year=2014&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2006-N-0515&posted_year=2014", "results": [{"value": 2014, "label": 2014, "count": 24, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-N-0515", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-N-0515&posted_year=2014&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-N-0515&posted_year=2014&_facet=posted_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-N-0515&posted_year=2014&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-N-0515&posted_year=2014&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-N-0515&posted_year=2014&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 2176.688610925339, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}